(News Bulletin 247) – The Paris Stock Exchange limited initiatives this Monday. The CAC 40 fell by 0.46% at the close, awaiting the publication this week of numerous macroeconomic data, including those relating to inflation in the United States and the euro zone.

No record this Monday on the Paris Stock Exchange. The CAC 40 ended this session down 0.46% to 7,929.82 points, moving away from its record levels reached on Friday.

The Parisian index opted for a break after having chained eight bullish sessions and gained nearly 2.6% last week. Nvidia’s stratospheric results published last week fueled this wind of optimism on global markets.

There, it is the data relating to inflation in the United States and Europe which will hold the attention of investors this week. Across the Atlantic, prices for personal consumption expenditures (PCE) – the US Federal Reserve’s (Fed) favorite inflation measure – for January will be published on Thursday, before euro zone inflation figures on Friday.

This data will be all the more scrutinized as it will give valuable indications on the future monetary policies of the Fed and the European Central Bank. The Fed’s latest minutes, released Wednesday evening, “did not provide much clarity on the timing of reductions, but highlighted members’ concerns about a premature easing of monetary policy,” comment Barclays economists.

In Paris, several major publications are planned this week. Bouygues, Edenred or Eurofins Scientific will publish this Tuesday before Saint-Gobain, Air France-KLM, Arkema or Veolia Environnement on Thursday.

The return of speculation on SMCP

In the meantime, the news is reduced to its strict minimum this Monday. The defense sector did well this Monday, with Thales gaining 2.3%.

Down at mid-session, Renault gained 0.6%. The diamond brand presented this Monday at the Geneva International Motor Show its new R5, the electric version of its iconic model from the 70s and 80s.

Conversely, Sanofi ended down 0.5% despite the publication of positive results for a phase 2 trial evaluating rilzabrutinib for the treatment of chronic urticaria in adults.

Excluding CAC 40, SMCP gained 3.3% while according to Les Echos, a decision by a London court could accelerate the process of restructuring the capital of the “accessible luxury” specialist.

Fnac Darty increased by 2.3% after gaining 7.8% on Friday in reaction to an annual publication appreciated by the markets.

On the foreign exchange market, the euro gained 0.3% to 1.0853 dollars. Oil is regaining color after dropping more than 2% on Friday. The April contract on North Sea Brent gained 0.7% to $81.34 per barrel while that on WTI listed in New York appreciated by 0.9% to $77.16 per barrel.